Baylis Medical Technologies Inc.

Baylis Medical Technologies is a medical device manufacturer specializing in endovascular intervention solutions for vascular and interventional procedures. The company designs and commercializes state-of-the-art access and crossing technologies that enable healthcare professionals to navigate complex vascular anatomy and treat previously challenging or unreachable lesions. Primary product lines include radiofrequency (RF) guidewires and steerable sheaths for peripheral vascular interventions, occlusion crossing, and stent-related procedures. Key products include PowerWire® Pro RF Guidewire (for crossing totally occluded peripheral vessels ≥3 mm, including stented vessels), PowerWire® Pulse RF Guidewire (with biliary intervention applications), and Passport® Steerable Sheath (for vascular navigation and precision access). The company operates manufacturing facilities in Mississauga, Ontario, Canada, with US operations headquartered in Fort Worth, Texas. Baylis supports clinical adoption through comprehensive online education, physician training programs, and clinical support services. Products are distributed globally to interventional cardiologists, vascular surgeons, and interventional radiologists. The company emphasizes evidence-based clinical outcomes, publishing and disseminating independent clinical studies through its Office of Scientific Affairs. Regional regulatory compliance and approval status vary by jurisdiction.